Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors

NCT00796484 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
33
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision

Conditions

Interventions

Sponsor

Exelixis